|
Match
|
Document |
Document Title |
|
|
7141407 |
Chickweed bioherbicides
The present invention relates to the use of a strain of Burkholderia andropogonis for controlling the growth of a weed belonging to the order Caryophyllales. The present invention also provides a...
|
|
|
6844182 |
Mutants which produce a potentiator of bacillus pesticidal activity
This invention is directed to Bacillus mutants which produce a factor which potentiates the pesticidal activity of a Bacillus related pesticide, a chemical pesticide and/or a virus with...
|
|
|
6224864 |
Antibiotic 10381A, and process for the preparation of anitbiotics 10381B
Antibiotic 10381a 1 , wherein R is hydrogen, is a cytosine-containing antibiotic producible by culturing the novel microorganism Streptomyces arginensis in an aqueous medium and isolation thereof....
|
|
|
6214340 |
Physiologically active substance sulphostin, process for producing the same, and use thereof
This invention provides a physiologically active substance having a strong dipeptidyl peptidase IV inhibitory activity. The physiologically active substance sulphostin is obtained by culturing a...
|
|
|
5985274 |
Antibiotic 10381A.sub.1 and process for the preparation of antibiotics 10381B
Antibiotic 10381a 1 , wherein R is hydrogen, is a cytosine-containing antibiotic producible by culturing the novel microorganism Streptomyces arginensis in an aqueous medium and isolation thereof....
|
|
|
5981234 |
Use of antibiotics 10381b to promote growth
Antibiotic 10381a 1 , wherein R is hydrogen, is a cytosine-containing antibiotic producible by culturing the novel microorganism Streptomyces arginensis in an aqueous medium and isolation thereof....
|
|
|
5948405 |
Fucans with low molecular weight having anticoagulant, antithrombinic and antithromobic activity
Fucans with low molecular weight having anticoagulant, antithrombinic and antithrombotic activity. Fucan sulfates having molecular weight between 14000 and 29000 Dalton show a remarkable...
|
|
|
5877147 |
Compounds for medicinal use
Muramyl peptide compounds are useful in the prophylaxis of cancers and particularly in the treatment of precancerous lesions associated with cancers of the mucosa or epithelium.
|
|
|
5843890 |
Antibiotic GE 2270 factors B.sub.1, B.sub.2, C.sub.1, C.sub.2, D.sub.1, D.sub.2, E and T
The present invention is directed to new antibiotic substances denominated antibiotic GE 2270 factors B 1 , B 2 , C 1 , C 2 , D 1 , D 2 , E and T, the addition salts thereof, the pharmaceutical...
|
|
|
5804186 |
Nerve cell differentiation promoter
A nerve cell differentiation promoter which comprises a physiologically active substance NK175203 or a pharmacologically acceptable salt thereof as an active ingredient is provided. It is expected...
|
|
|
5736510 |
Antibiotics 10381v, w, x,y, z1, z2, pre-b and t
Antibiotics 10381v, w, x, y, z1, z2, pre-b and t are antibiotics producible by culturing the microorganism Streptomyces arginensis in an aqueous medium and isolation thereof. The structure of...
|
|
|
5695984 |
Process for the preparation of antibiotics 10381B
Antibiotic 10381a 1 , wherein R is hydrogen, is a cytosine-containing antibiotic producible by culturing the novel microorganism Streptomyces arginensis in an aqueous medium and isolation thereof....
|
|
|
5567676 |
Glycopeptide antibiotics
The present invention concerns new antiobiotic substances demoninated de-acyl antibiotics A40926, de-acyl antibiotic A 40926P and antibiotic A 40926 amino glucronyl aglycon, and the use of these...
|
|
|
5514649 |
Antibiotic GE 2270 factors C.sub.2a
The present invention is directed to a new antibiotic substance denominated antibiotic GE 2270 factor C 2a , the addition salts thereof, the pharmaceutical compositions thereof and its use as...
|
|
|
5505944 |
Physiologically active substance NK175203, process for production thereof and pharmaceutical use thereof
Physiologically active substance NK175203 is produced by culturing bacteria belonging to the genus Streptomyces and capable of producing the physiologically active substance NK175203, and...
|
|
|
5401709 |
Antibiotic AB-041 derived from Streptomyces sp. NCIMB 40428, herbicidal compositions, and methods of use
The antibiotic AB-041 is described, obtained by controlled aerobic cultivation of Streptomyces sp. NCIMB 40428 in an aqueous culture medium. The antibiotic AB-041 exhibits biological activity, and...
|
|
|
5364624 |
WS7622A mono- or di-sulfate, process for preparation thereof and use thereof
A degenerative disease selected from the group consisting of cystic fibrosis, chronic bronchitis and bronchiectasia is treated by administering to a subject a therapeutically effective amount of...
|
|
|
5306496 |
Antibiotics NK374186A, NK374186B, NK374186B3 and NK374186C3, process for producing the same, and use of the same
Novel antibiotics NK374186A, NK374186B, NK374186B3 and NK374186C3 having antibacterial, antineoplastic, immunomodulation, and liver regeneration promoting activities are provided. NK374186A,...
|
|
|
5279826 |
Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
A method for therapy of disseminated intravascular coagulation, or chronic respiratory tract infectious disease characterized by administering to a patient in need thereof an effective dose...
|
|
|
5229362 |
Antibiotic A10255 complex and factors, and process and production therefor
Newly-discovered antibiotic A10255 factors B, C, E, F, G, H, and J are produced by submerged aerobic fermentation of Streptomyces gardneri NRRL 15537 and NRRL 18260 or an A10255-producing variant...
|
|
|
5124150 |
Process for preparing antiviral antibiotic BU-3889V
Production of an antiviral antibiotic complex, BU-3889V and its bioactive components A 1 , A 2 , A 3 , D 1 , D 2 and D 3 , by fermentation of a BU-3889V producing strain of the new microorganism...
|
|
|
5037651 |
Dihydro derivatives of LL-E33288 antibiotics
Dihydro derivatives of LL-E33288, BBM-1075 FR-900405, FR-900406, PD 114759, PD 115028, CL-1577A, CL-1577B, CL-1577D, CL-1577E and CL-1724 antibiotics/antitumor agents are disclosed and described,...
|
|
|
5013550 |
Antibiotics called "chloropolysporins B and C", a process for their preparation, and their therapeutic and veterinary use
Novel compounds, called chloropolysporins B and C, and salts thereof have antibiotic properties and would appear to be members of the class of glycopeptide antibiotics containing chlorine. They may...
|
|
|
4999196 |
Compound DC-107 produced by Streptomyces sp.
A novel compound, DC-107, is produced by culturing a microorganism belonging to the genus Streptomyces. It is useful as a medicine because of its antibacterial and anti-tumor activity.
|
|
|
4950477 |
Method of preventing and treating pulmonary infection by fungi using aerosolized polyenes
This invention concerns a method of preventing a pulmonary infection by a fungus in a subject susceptible to infection by the fungus comprising administering to the subject an amount per dose in an...
|
|
|
4921700 |
BBM-1675c and d antitumor antibiotics
There is provided new antitumor antibiotic substances designated herein as BBM-1675C and BBM-1675D, said substances being produced by selective chemical hydrolysis of the bioactive components...
|
|
|
4900815 |
Sulfated polysaccharide DS4152
A sulfated polysaccharide DS4152 useful as an angiogenesis inhibitor or antitumor agent is provided selectively. As the sodium salt, it has the following physicochemical characteristics. Molecular...
|
|
|
4885170 |
Antibiotic A80509
New antibiotic A80509, its C 1 -C 7 -alkyl ester derivatives and salts are useful antibacterial and anticoccidial agents and improve feed efficiency and growth in animals. Methods of making...
|
|
|
4785078 |
Transformation product of thiosporamicin
A new sulfur-containing polypeptide antibiotic produced by the hydrolysis of thiosporamicin (CP-46,192) is useful for the improving feed utilization efficiency in poultry and swine.
|
|
|
4752469 |
Potentiators of beta-lactam antibiotics
Cultivation of the microorganism Chromobacterium violaceum A.T.C.C. No. 31532 yields two novel compounds which have been designated SQ 28,504 and SQ 28,546 in addition to EM5117, a previously...
|
|
|
4719109 |
EM5596--an antibiotic
A novel antibiotic substance EM5596 is prepared by cultivation of a strain of the microorganism Micrococcus luteus A.T.C.C. No. 53598.
|
|
|
4684644 |
Basic monocarboxyamide derivatives of actagardine having antibiotic activity and compositions thereof
The present invention is directed to a class of basic monocarboxyamide derivatives of actagardine. Actagardine (INN) is an antibiotic substance produced by actinoplanes strains such as Actinoplanes...
|
|
|
4675187 |
BBM-1675, a new antibiotic complex
A novel antibiotic complex designated herein as BBM-1675 complex is produced by fermentation of certain novel strains of Actinomadura verrucosospora. The complex may be separated into two major...
|
|
|
4661353 |
CL-1577-B.sub.4 compound, its production and use
CL-1577-B 4 compound is derived by the solvolysis under anhydrous conditions of either CL-1577A compound of CL-1577B compound, obtained from the fermentative action of a purified strain of...
|
|
|
4661352 |
WS 7739 substances, their preparation and pharmaceutical composition containing the same
This invention relates to a biologically active WS-7739-A substance and a biologically active WS-7739-B substance which have pharmacological activities and are useful for the treatment of asthma,...
|
|
|
4650679 |
Animal feed block compositions
The present invention relates to animal feed block compositions containing a growth promoter, such as avoparcin, and an organic or mineral acid. The feed blocks of this invention exhibit improved...
|
|
|
4626503 |
Antitumor agents LL-D49194α.sub.1, LL-D49194β.sub.1, LL-D49194β.sub.2, LL-D49194β.sub.3, LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω.sub.1, LL-D49194ω.sub.2, and LL-D49194ω.sub.3
Antitumor agents LL-D49194α 1 , LL-D49194β 1 , LL-D49194β 2 , LL-D49194β 3 , LL-D49194γ, LL-D49194δ, LL-D49194ε, LL-D49194ξ, LL-D49194η, LL-D49194ω, LL-D49194ω 2 and LL-D49194ω 3 .
|
|
|
4615975 |
Purified culture of Actinomadura verrucaspora subspecies veractimyces
A purified isolate of Actinomadura verrucaspora subspecies veractimycin is capable of producing a complex of sulfur-containing antibiotic compounds having anti-tumor activity in recoverable amounts...
|
|
|
4578271 |
Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions
Novel compounds designated as WS 6049-A and WS 6049-B are disclosed, as well as compositions containing the compounds thereof, a method of treating microbial infections, a method of prolonging the...
|
|
|
4565699 |
Composition of matter and process
Novel antibiotic U-68,204 is produced in a fermentation under controlled conditions using a biologically pure culture of the microorganism Streptomyces thiolactonus, NRRL 15439. This antibiotic is...
|
|
|
4554162 |
CL-1724 Antibiotic compounds, their production and use
A strain of actinomycete, NRRL 15758, is capable of producing the CL-1724 complex of compounds under conditions of aerobic fermentation in the presence of assimilable sources of carbon and...
|
|
|
4539203 |
CL-1577D And CL-1577E antibiotic/antitumor compounds, their production and use
Compounds CL-1577D and CL-1577E are prepared by cultivation of a purified isolate of Actinomycete designated ATCC 39363 in a culture medium having assimilable sources of carbon and nitrogen. The...
|
|
|
4530835 |
CL-1577 Antibiotic compounds and their production
A purified isolate of an actinomycete identified as ATCC 39363 is capable of producing a complex of sulfur-containing antibiotic compounds having activity against transplanted tumors. Antibiotic...
|
|
|
4507282 |
High molecular weight antitumor antibiotic AN-7D
A high molecular weight peptide antibiotic designated as AN-7D which is effective as an agent.
|
|
|
4505895 |
Antibiotic 273.sub.a1
Novel and useful antibiotics designated 273a 1<1unull>s α and 273a 1<1unull>s β can be produced in a fermentation using Streptomyces paulus, strain 273, NRRL 12251. These antibiotics are active...
|
|
|
4500303 |
Idler mechanism
An idler mechanism for maintaining tension on a drive belt in a drive belt system comprising an idler arm, a pulley mounted on the arm for rotation about a rotational axis, a pivotally adjustable...
|
|
|
4478831 |
Antibiotics, pharmaceutical compositions and method of use
The antibiotics S 54832/A-I, S 54832/A-II, S 54832/A-III and S 54832/A-IV are obtained from a new Micromonospora globosa strain.
|
|
|
4394377 |
Ruminant animal performance by co-administering choline and propionate enchancers
The availability of supplemental dietary choline to animals with a developed rumen is increased by co-administering choline or choline compounds with a propionate-enhancing antibiotic compound.
|
|
|
4393046 |
Combination of thiopeptin and other related sulfur-containing cyclic polypeptide antibiotics with rumen-active diimides to improve ruminant feed efficiency
Combinations of thiopeptin or one of its analogs with a pyromellitic diimide are shown to synergistically increase the feed efficiency of economically important ruminant animals, especially cattle,...
|
|
|
4375462 |
A-32724 Antibiotics and process for production thereof
Antibiotic A-32724 complex, comprising microbiologically-active, related factors A, B and C, is produced by submerged, aerobic fermentation of a strain of Chaetomella raphigera Swift NRRL 12331....
|